Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection

NACompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
HIV Infections
Interventions
DIETARY_SUPPLEMENT

Vitamin D supplement

Vitamin D3 (cholecalciferol), 50,000 IU as a single capsule, will be administered orally to subjects in Groups A and C once every four weeks during study visits.

OTHER

Placebo

A placebo will be administered orally to subjects in Groups B and D once every four weeks during study visits.

Trial Locations (15)

10128

Mount Sinai Hospital, New York

10467

Montefiore Medical Center, The Bronx

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21204

University of Maryland Medical School, Baltimore

33101

University of Miami, Miami

33316

Children's Diagnostic and Treatment Center, Fort Lauderdale

33606

University of South Florida, Tampa

38105

St. Jude Childrens Research Hospital, Memphis

60612

Stroger Hospital of Cook County, Chicago

60614

Childrens Memorial Hospital, Chicago

70112

Tulane University, New Orleans

90027

Children's Hopsital of Los Angeles, Los Angeles

94143

University of California at San Francisco, San Francisco

00936

University of Puerto Rico, San Juan

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00490412 - Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection | Biotech Hunter | Biotech Hunter